Toggle navigation
Toggle navigation
Home
DCUM Forums
Nanny Forums
Events
About DCUM
Advertising
Search
Recent Topics
Hottest Topics
FAQs and Guidelines
Privacy Policy
Your current identity is: Anonymous
Login
Preview
Subject:
Forum Index
»
Political Discussion
Reply to "RFKjr Tapped to Head HHS"
Subject:
Emoticons
More smilies
Text Color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Violet
White
Black
Font:
Very Small
Small
Normal
Big
Giant
Close Marks
[quote=Anonymous]Let’s END the nonsensical arguments about vaccine approval here is the procedures that all vaccines must go through: In the United States, vaccines must go through a rigorous process of development, testing, and review before they can be approved or authorized by the Food and Drug Administration (FDA). The standard procedure includes the following steps: 1. Preclinical Research • Laboratory and Animal Testing: Researchers test the vaccine candidate in cells and animals to evaluate its safety and potential efficacy. • Objective: Determine whether the vaccine triggers an immune response and whether it is safe enough for human trials. 2. Investigational New Drug (IND) Application • Before starting clinical trials in humans, vaccine developers submit an IND application to the FDA. • The application includes preclinical data, manufacturing details, and the proposed clinical trial plan. • FDA reviews the IND to ensure the vaccine is safe to test in humans. 3. Clinical Trials Phase 1: Safety and Dosage • Participants: A small group (20–100) of healthy volunteers. • Focus: Assess the safety of the vaccine, determine appropriate dosage, and evaluate the immune response. Phase 2: Expanded Safety and Immunogenicity • Participants: Hundreds of people, including those from groups intended to receive the vaccine. • Focus: Refine the dosage, continue safety monitoring, and further assess the immune response. Phase 3: Efficacy and Safety in Large Populations • Participants: Thousands to tens of thousands of volunteers. • Focus: Determine the vaccine’s effectiveness in preventing the targeted disease and continue safety monitoring. 4. Biologics License Application (BLA) • After successful clinical trials, the developer submits a BLA to the FDA. • The BLA includes all data from preclinical and clinical studies, along with manufacturing and labeling information. • FDA experts review the BLA to determine if the vaccine is safe, effective, and produced to high-quality standards. 5. Advisory Committee Review • The FDA often convenes the Vaccines and Related Biological Products Advisory Committee (VRBPAC), a panel of independent experts, to review the data and provide recommendations. 6. FDA Decision • Approval: If the vaccine meets all safety, efficacy, and quality standards, the FDA approves it. • Emergency Use Authorization (EUA): In urgent public health situations, the FDA may issue an EUA to allow temporary use of a vaccine based on preliminary data. 7. Post-Market Surveillance • Phase 4 Studies: Additional studies to monitor long-term safety and efficacy. • VAERS: The Vaccine Adverse Event Reporting System collects and analyzes reports of side effects. • Continuous Monitoring: Ongoing reviews of manufacturing processes and adverse event data. This process ensures vaccines are both safe and effective for public use.[/quote]
Options
Disable HTML in this message
Disable BB Code in this message
Disable smilies in this message
Review message
Search
Recent Topics
Hottest Topics